Drug
Cd33 Cd3 Bsab
Cd33 Cd3 Bsab: highest development phase Phase 1, developed by Y-mAbs Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Y-mAbs Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CD33*CD3 BsAb NCT05077423 | Phase 1 | AML, Childhood |
Latest
No recent events.
Follow Cd33 Cd3 Bsab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.